Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population

Journal of Clinical Laboratory Analysis

Volumn 19, Issue 6, 2005, Pages 241-246

  Djurić, Tamara ^a   Živković, Maja ^a   Stanković, Aleksandra ^a   Mečanin, Sanja ^a   Alavantić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Endothelial nitric oxide synthase; Gender specific association; Matrix metalloproteinase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; STROMELYSIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIUM CELL; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STATISTICAL SIGNIFICANCE; YUGOSLAVIA;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS; YUGOSLAVIA;

EID: 28444460716     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20085     Document Type: Article

References (35)

1. Lew EA. Hypertension and longevity. In: JH Laragh, BM Brenner, editors. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven, 1990. p. 175-190.
2. Intengan HD, Schiffrin EL. Vascular Remodeling in Hypertension. Roles of Apoptosis, Inflammation, and Fibrosis. Hypertension 2001;38:581-587.
3. Cooke JP, Rossitch Jr E, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663-1671.
4. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003;92:1254-1261.
5. Woessner Jr JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
6. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci 1991;88:8154-8158.
7. Veldman BA, Spiering W, Doevendans PA, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-2027.
8. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731-736.
9. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999;33:937-942.
10. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Nature 1994;198:1027-1033.
11. Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3-8.
12. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Nothern Japan. Life Science 2000;26:2557-2562.
13. Kato N, Sugiyama T, Morita H, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999;33:933-936.
14. Lacolley P, Gautier C, Poirier O, Pannier B, Cambien F, Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. Journal of Hypertension 1998;16:31-35.
15. Ye S, Watts GF, Mandalia S, Humphries, Henney AM. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Brit Heart J 1995;73:209-215.
16. Ye S, Erikson P, Hamsten A, Kurkinen M, Humpries SE, Henney AM. Progression of coronary atherosclerosis is associated with common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271:13055-13060.
17. Kingwell BA, Medley TL, Waddell TK, Cole TJ, Dart AM, Jennings GL. Large artery stiffness: structural and genetic aspects. Clinical and Experimental Pharmacology and Physiology 2001;28:1040-1043.
18. Beilby JP, Chapman CML, Palmer LJ, McQuillan BM, Thompson PL, Hung J. Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population. Journal of Hypertension 2005;23:537-542.
19. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Kunkel LM, Smith KD, Boyer SH, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977;74:1245-1249.
21. Dunleavey L, Beyzade S, Shu Y. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 2000;151:587-589.
22. Hirata RDC, Salazar A, Cavalli SA, et al. A method to detect the G894T polymorphism of the NOS3 gene. Clinical validation in familial hypercholesterolemia. Clin Chem Lab Med 2002;40:436-440.
23. Safar ME, Smulyan H. Hypertension in Women. Review. Am J Hypertens 2004;17:82-87.
24. Berry KL, Cameron JD, Dart AM, et al. Large-Artery Stiffness Contributes to the Greater Prevalence of Systolic Hypertension in Elderly Women. J Am Geriatr Soc 2004;52:368-373.
25. Staessen JA, van der Heijden-Spek JJ, Safar ME, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001;15:511-518.
26. Fischer GM. In vivo effects of estradiol on collagen and elastin dynamics in rat aorta. Endocrinology 1972;91:1227-1232.
27. Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S. Hypertension: increase of collagen biosynthesis in arteries but not in vein. Science 1977;198:403-405.
28. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998;1773-1779.
29. Stankovic A, Zivkovic M, Alavantic D. Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Lab Invest 2002;62:469-476.
30. Higaki J, Baba S, Katsuya T, et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: The Suita Study. Circulation 2000;10:2060-2065.
31. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased Expression of Matrix Metalloproteinases and Matrix Degrading Activity in Vulnerable Regions of Human Atherosclerotic Plaques. J Clin Invest 1994;94:2493-2503.
32. Gnasso A, Motti C, Irace C, et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000;20:1600-1605.
33. Rauramaa R, Vaisanen SB, Luong L-A, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Atherioscler Thromb Vasc Biol 2000;20:2657-2662.
34. Laviades C, Varo N, Fernandez J, et al. Abnormalities of the Extracellular Degradation of Collagen Type 1 in Essential Hypertension. Circulation 1998;98:535-540.
35. Benjafield AV. Morris BJ. Association analyses of endothelial nitric oxide synthase gene polymorphism in essential hypertension. Am J Hypertens 2000;13:994-998.